Synthesis and evaluation of functionalized indoles as antimycobacterial and anticancer agents

Molecular Diversity

Volumn 16, Issue 3, 2012, Pages 525-539

  Cihan Üstündağ, Gökçe ^a   Çapan, Gültaze ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antimycobacterial activity; Antitumor activity; Indole; Spirothiazolidinone

Indexed keywords

5 FLUORO 3 PHENYL N (8 PHENYL 3 OXO 1 THIA 4 AZASPIRO[4.5]DEC 4 YL) 1H INDOLE 2 CARBOXAMIDE; 5 FLUORO 3 PHENYL N (8 PROPYL 3 OXO 1 THIA 4 AZASPIRO[4.5]DEC 4 YL) 1H INDOLE 2 CARBOXAMIDE; 5 FLUORO 3 PHENYL N2 (4 PHENYLCYCLOHEXYLIDENE) 1H INDOLE 2 CARBOHYDRAZIDE; 5 FLUORO 3 PHENYL N2 (4 PROPYLCYCLOHEXYLIDENE) 1H INDOLE 2 CARBOHYDRAZIDE; 5 FLUORO N (2 METHYL 3 OXO 1 THIA 4 AZASPIRO[4.5]DEC 4 YL) 3 PHENYL 1H INDOLE 2 CARBOXAMIDE; 5 FLUORO N (2 METHYL 8 PHENYL 3 OXO 1 THIA 4 AZASPIRO[4.5]DEC 4 YL) 3 PHENYL 1H INDOLE 2 CARBOXAMIDE; 5 FLUORO N (2 METHYL 8 PROPYL 3 OXO 1 THIA 4 AZASPIRO[4.5]DEC 4 YL) 3 PHENYL 1H INDOLE 2 CARBOXAMIDE; 5 FLUORO N (3 OXO 1 THIA 4 AZASPIRO[4.5]DEC 4 YL) 3 PHENYL 1H INDOLE 2 CARBOXAMIDE; 5 FLUORO N (8 ETHYL 3 OXO 1 THIA 4 AZASPIRO[4.5]DEC 4 YL) 3 PHENYL 1H INDOLE 2 CARBOXAMIDE; 5 FLUORO N (8 METHYL 3 OXO 1 THIA 4 AZASPIRO[4.5]DEC 4 YL) 3 PHENYL 1H INDOLE 2 CARBOXAMIDE; 5 FLUORO N2 (4 METHYLCYCLOHEXYLIDENE) 3 PHENYL 1H INDOLE 2 CARBOHYDRAZIDE; ANTIMYCOBACTERIAL AGENT; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; N (2,8 DIMETHYL 3 OXO 1 THIA 4 AZASPIRO[4.5]DEC 4 YL) 5 FLUORO 3 PHENYL 1H INDOLE 2 CARBOXAMIDE; N (8 ETHYL 2 METHYL 3 OXO 1 THIA 4 AZASPIRO[4.5]DEC 4 YL) 5 FLUORO 3 PHENYL 1H INDOLE 2 CARBOXAMIDE; N2 (4 ETHYLCYCLOHEXYLIDENE) 5 FLUORO 3 PHENYL 1H INDOLE 2 CARBOHYDRAZIDE; N2 CYCLOHEXYLIDENE 5 FLUORO 3 PHENYL 1H INDOLE 2 CARBOHYDRAZIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; GROWTH INHIBITION; LEUKEMIA CELL LINE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 84869499846     PISSN: 13811991     EISSN: 1573501X     Source Type: Journal    
DOI: 10.1007/s11030-012-9385-y     Document Type: Article

References (33)

1. World Health Organization Tuberculosis Fact Sheet, November (2010), No. 104, http://www.who.int/mediacentre/factsheets/fs104/en/. Accessed 15 March 2011
2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021. doi:10.1001/archinte.163.9. 1009 (Pubitemid 36548927)
3. Espinal MA (2003) The global situation of MDR-TB. Tuberculosis 83:44-51. doi:10.1016/S1472-9792(02)00058-6 (Pubitemid 36686747)
4. Mckinney JD, Jacobs WRJ, Bloom BR (1998) Emerging infections. Academic Press, New York
5. Lowe SW, Lin AW (2000) Apoptosis in cancer. Carcinogenesis 21:485-495. doi:10.1093/carcin/21.3.485 (Pubitemid 30137934)
6. Kaelin WG (2005) The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer 5:689-698. doi:10.1038/nrc1691 (Pubitemid 41486362)
7. Sobin BA (1952) A new Streptomyces antibiotic. J Am Chem Soc 74:2947-2948. doi:10.1021/ja01131a526
8. Grundy WE, Whitman AI, Rdzok EG, Rdzok EJ, Hanes ME, Sylvester JC (1952) Actithiazic acid. I. Microbiological studies. Antibiot Chemother 2:399-408
9. Sun L, Tran N, Tang F, App H, Hirth P, McMahon G, Tang C (1998) Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J Med Chem 41:2588-2603. doi:10.1021/jm980123i (Pubitemid 28321908)
10. Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Varoli L, Kunkel MW (2006) Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones. J Med Chem 49:6922-6924. doi:10.1021/jm0607808 (Pubitemid 44749758)
11. Karali N, Gürsoy A, Kandemirli F, ShvetsN,Kaynak FB, Özbey S, Kovalishyn V, Dimoglo A (2007) Synthesis and structure-antituberculosis activity relationship of 1H-indole-2,3-dione derivatives. Bioorg Med Chem 15:5888-5904. doi:10.1016/j.bmc.2007.05.063 (Pubitemid 47043467)
12. Karthikeyan SV, Perumal S, Shetty KA, Yogeeswari P, Sriram D (2009) A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles. Bioorg Med Chem Lett 19:3006-3009. doi:10.1016/j.bmcl.2009.04.029
13. Sonar VN, Crooks PA (2009) Synthesis and antitubercular activity of a series of hydrazone and nitrovinyl analogs derived from heterocyclic aldehydes. J Enzym Inhib Med Chem 24:117-124. doi:10.1080/14756360801915526
14. Zampieri D, Mamolo MG, Laurini E, Scialino G, Banfi E, Vio L (2009) 2-Aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds - conventional heating in comparison with MW-assisted synthesis. Arch Pharm Chem Life Sci 342:716-722. doi:10.1002/ardp.200900031
15. Güzel Ö, Terzioǧlu N, Çapan G, Salman A (2006) Synthesis and biological evaluation of new 5-methyl-N-(3-oxo-1-thia-4- azaspiro[4.5]-dec-4-yl)-3-phenyl-1H-indole-2-carboxamide derivatives. Arkivoc xii:98-110 (Pubitemid 44238561)
16. Aquino TM, Liesen AP, Silva REA, Lima VT, Carvalho CS, Faria AR, Araujo JM, Lima JG, Alves AJ, Melo EJT, Goes AJS (2008) Synthesis, anti-Toxoplasma gondii and antimicrobial activities of benzaldehyde 4-phenyl-3- thiosemicarbazones and 2-[(phenylmethylene)hydrazono]-4-oxo-3-phenyl-5- thiazolidineacetic acids. Bioorg Med Chem 16:446-456. doi:10.1016/j.bmc.2007.09. 025
17. Ulusoy N (2002) Synthesis and antituberculosis activity of cyclo-alkylidenehydrazide and 4-aza-1-thiaspiro[4.5]decan-3-one derivatives of imidazo[2,1-b]thiazole. Arzneim-Forsch 52:565-571. doi:10.1002/chin.200244143 (Pubitemid 34800163)
18. Aridoss G, Amirthaganesan S, Kim MS, Kim JT, Jeong YT (2009) Synthesis, spectral and biological evaluation of some new thiazolidinones and thiazoles based on t-3-alkyl-r-2,c-6-diarylpiperidin-4-ones. Eur J Med Chem 44:4199-4210. doi:10.1016/j.ejmech.2009.05.015
19. Jaju S, Paklar M, Maddi V, Ronad P, Mamledesai S, Satyanarayana D, Ghatole M (2009) Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives. Arch Pharm Chem Life Sci 342:723-731. doi:10.1002/ardp.200900001
20. ZhangHZ, Drewe J, Tseng B, Kasibhatla S,CaiSX (2004) Discovery and SAR of indole-2-carboxylic acid benzylidene-hydrazides as a new series of potent apoptosis inducers using a cell-based HTS assay. Bioorg Med Chem 12:3649-3655. doi:10.1016/j.bmc.2004.04.017 (Pubitemid 38746867)
21. Wang JJ, Shen YK, Hu WP, Hsieh MC, Lin FL, Hsu MK, Hsu MH (2006) Design, synthesis, and biological evaluation of pyrrolo[ 2,1-c][1,4]benzodiazepine and indole conjugates as anticancer agents. J Med Chem 49:1442-1449. doi:10.1021/jm050956q (Pubitemid 43271897)
22. Kumar D, Kumar NM, Chang KH, Shah K (2010) Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles. Eur J Med Chem 45:4664-4668. doi:10.1016/j.ejmech.2010.07.023
23. Brancale A, Silvestri R (2007) Indole, a core nucleus for potent inhibitors of tubulin polymerization. Med Res Rev 27:209-238. doi:10.1002/med.20080 (Pubitemid 46281147)
24. Liou JP,Wu CY, Hsieh HP, Chang CY, Chen CM, Kuo CC, Chang JY (2007) 4-and 5-Aroylindoles as novel classes of potent antitubulin agents. J Med Chem 50:4548-4552. doi:10.1021/jm070557q (Pubitemid 47378853)
25. Romagnoli R, Baraldi PG, Sarkar T, Carrion MD, Cara CL, Cruz-Lopez O, Preti D, Tabrizi MA, Tolomeo M, Grimaudo S, Cristina AD, Zonta N, Balzarini J, Brancale A, Hsieh HP, Hamel E (2008) Synthesis and biological evaluation of 1-methyl-2-(3′,4′,5′-trimethoxybenzoyl)-3-aminoindoles as a newclass of antimitotic agents and tubulin inhibitors. J Med Chem 51:1464-1468. doi:10.1021/jm7011547 (Pubitemid 351480406)
26. Nickel B, Szelenyi I, Schmidt J, Emig P, Reichert D, Günther E, Brune K (1999) Preparation of indolylglyoxylamides as antitumor agents. PCT International Patent Application WO 9951224
27. Bacher G, Nickel B, Emig P, Vanhoefer U, Seeber S, Shandra A, Klenner T, Beckers T (2001) D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity. Cancer Res 61:392-399 (Pubitemid 32106651)
28. Wienecke A, Bacher G (2009) Indibulin, a novel microtubule inhibitor, discriminates between mature neuronal and nonneuronal tubulin. Cancer Res 69:171-177. doi:10.1158/0008-5472.CAN-08-1342
29. Bamaung NY, Craig RA, Kawai M, Wang J (2001) 3-Substituted indole angiogenesis inhibitors. US Patent 6323228 B1 20011127
30. Collins LA, Franzblau SG (1997) Microplate Alamar Blue assay versus BACTEC460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 41:1004-1009 (Pubitemid 27194176)
31. Alley MC, Scudiero DA, Monks PA, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589-601 (Pubitemid 18056527)
32. Grever MR, Schepartz SA, Chabner BA (1992) The National Cancer Institute: cancer drug discovery and development program. Semin Oncol 19:622-638 (Pubitemid 23004840)
33. Boyd MR, Paull KD (1995) Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Res 34:91-109. doi:10.1002/ddr.430340203